BR9815632A - Fragmento de ácido nucléico isolado e método de obtenção do mesmo, gene quimérico, célula hospedeira transformada, método de alteração do nìvel de expressão de uma enzima e produto - Google Patents

Fragmento de ácido nucléico isolado e método de obtenção do mesmo, gene quimérico, célula hospedeira transformada, método de alteração do nìvel de expressão de uma enzima e produto

Info

Publication number
BR9815632A
BR9815632A BR9815632-2A BR9815632A BR9815632A BR 9815632 A BR9815632 A BR 9815632A BR 9815632 A BR9815632 A BR 9815632A BR 9815632 A BR9815632 A BR 9815632A
Authority
BR
Brazil
Prior art keywords
enzyme
expression
nucleic acid
host cell
isolated nucleic
Prior art date
Application number
BR9815632-2A
Other languages
English (en)
Inventor
Gary Michael Fader
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of BR9815632A publication Critical patent/BR9815632A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

<B>"FRAGMENTO DE áCIDO NUCLéICO ISOLADO E MéTODO DE OBTENçãO DO MESMO, GENE QUIMéRICO, CéLULA HOSPEDEIRA TRANSFORMADA, MéTODO DE ALTERAçãO DO NìVEL DE EXPRESSãO DE UMA ENZIMA E PRODUTO"<D> A presente invenção refere-se a um fragmento de ácido nucléico isolado que codifica enzimas da soja que catalisam etapas na biosíntese de isoflavonas, sendo que a enzima é um membro selecionado do grupo que consiste em chalcona isomerase, isoflavona redutase e vestitona redutase. A invenção também se refere à construção de genes quiméricos que codificam toda ou uma parte substancial das enzimas, na orientação de sentido ou de anti-sentido, onde a expressão do gene quimérico resulta na produção de níveis alterados da enzima em uma célula hospedeira transformada.
BR9815632-2A 1997-09-17 1998-09-17 Fragmento de ácido nucléico isolado e método de obtenção do mesmo, gene quimérico, célula hospedeira transformada, método de alteração do nìvel de expressão de uma enzima e produto BR9815632A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/931,668 US6521433B1 (en) 1997-09-17 1997-09-17 cDNA sequences from plants that encode activities associated with isoflavone biosynthesis
PCT/US1998/019553 WO1999014351A1 (en) 1997-09-17 1998-09-17 Isoflavone biosynthetic enzymes

Publications (1)

Publication Number Publication Date
BR9815632A true BR9815632A (pt) 2001-01-16

Family

ID=25461157

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815632-2A BR9815632A (pt) 1997-09-17 1998-09-17 Fragmento de ácido nucléico isolado e método de obtenção do mesmo, gene quimérico, célula hospedeira transformada, método de alteração do nìvel de expressão de uma enzima e produto

Country Status (5)

Country Link
US (3) US6521433B1 (pt)
EP (1) EP1015614A1 (pt)
AU (1) AU9493498A (pt)
BR (1) BR9815632A (pt)
WO (1) WO1999014351A1 (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6924128B2 (en) 1994-12-06 2005-08-02 Targeted Genetics Corporation Packaging cell lines for generation of high titers of recombinant AAV vectors
US6989264B2 (en) 1997-09-05 2006-01-24 Targeted Genetics Corporation Methods for generating high titer helper-free preparations of released recombinant AAV vectors
WO2000004175A1 (en) * 1998-07-14 2000-01-27 Unilever Plc Methods and composition for modulating flavonoid content
IL128193A (en) * 1999-01-22 2008-03-20 Yeda Res & Dev Rhamnosyl-transferase gene and uses thereof
US6893865B1 (en) 1999-04-28 2005-05-17 Targeted Genetics Corporation Methods, compositions, and cells for encapsidating recombinant vectors in AAV particles
DE19930570A1 (de) * 1999-07-02 2001-01-11 Max Planck Gesellschaft Pflanzen mit veränderter Genexpression
US7792645B2 (en) * 2000-08-30 2010-09-07 The Salk Institute For Biological Studies Three-dimensional structure of chalcone isomerase and methods of use thereof
AUPR324101A0 (en) * 2001-02-21 2001-03-15 Commonwealth Scientific And Industrial Research Organisation Novel gene and uses therefor to modify pasture qualities of crops
AUPR811301A0 (en) * 2001-10-05 2001-10-25 Agresearch Limited Manipulation of flavonoid biosynthesis
US7304207B2 (en) * 2001-10-29 2007-12-04 Exelixis, Inc. Identification and characterization of an Anthocyanin mutant (ANT1) in tomato
US20050150008A1 (en) * 2001-11-07 2005-07-07 Agrigenesis Biosciences Limited Compositions isolated from forage grasses and methods of use
AU2002360228B8 (en) * 2001-11-07 2008-12-04 Genesis Research And Development Corporation Limited Compositions from the grasses lolium perenne and festuca arundinacea
EP1478757A2 (en) 2002-02-28 2004-11-24 Unilever Plc Production of dadzein in transgenic plants
WO2003093464A1 (en) * 2002-05-06 2003-11-13 Genesis Research And Development Corporation Limited Compositions isolated from forage grasses and methods for their use
AU2003263740A1 (en) 2002-06-14 2003-12-31 Syngenta Participations Ag Flavonol expressing domesticated tomato and method of production
US20050245492A1 (en) * 2004-04-28 2005-11-03 Lephart Edwin D Use of equol for treating skin diseases
US8668914B2 (en) * 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
WO2004039327A2 (en) * 2002-10-29 2004-05-13 Colorado State University Research Foundation Use of equol for treating androgen mediated diseases
JP2006504409A (ja) * 2002-07-24 2006-02-09 チルドレンズ　ホスピタル　メディカル　センター 鏡像異性のエクオールを含有する組成物および製品、およびその製造方法
US7202398B2 (en) * 2002-08-16 2007-04-10 E. I. Du Pont De Nemours And Company Chalcone isomerase
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
US8460864B2 (en) * 2003-01-21 2013-06-11 Ptc Therapeutics, Inc. Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same
US9068234B2 (en) 2003-01-21 2015-06-30 Ptc Therapeutics, Inc. Methods and agents for screening for compounds capable of modulating gene expression
US8426194B2 (en) 2003-01-21 2013-04-23 Ptc Therapeutics, Inc. Methods and agents for screening for compounds capable of modulating VEGF expression
EP1618186A2 (en) * 2003-04-25 2006-01-25 Exelixis Plant Sciences, Inc. Genes upregulated in a tomato plant having an increased anthocyanin content phenotype
WO2005049868A1 (en) * 2003-11-17 2005-06-02 Pct Therapeutics, Inc. Methods and agents for screening for compounds capable of modulating her2 expression
AR047658A1 (es) 2004-02-03 2006-02-01 Cargill Inc Concentrado de proteinas y corriente acuosa con carbohidratos hidrosolubles
CA2497087A1 (en) * 2004-03-09 2005-09-09 Commonwealth Scientific And Industrial Research Organisation Novel genes encoding proteins involved in proanthocyanidin synthesis
CA2573490A1 (en) * 2004-07-10 2006-01-26 The Research Foundation Of State University Of New York Production of flavonoids by recombinant microorganisms
AU2007203279A1 (en) * 2007-01-11 2008-07-31 Commonwealth Scientific And Industrial Research Organisation Novel gene encoding MYB transcription factor involved in proanthocyamidin synthesis
US8283115B1 (en) 2007-06-20 2012-10-09 Ptc Therapeutics, Inc. Methods of screening for compounds for treating muscular dystrophy using UTRN mRNA translation regulation
US8283116B1 (en) 2007-06-22 2012-10-09 Ptc Therapeutics, Inc. Methods of screening for compounds for treating spinal muscular atrophy using SMN mRNA translation regulation
US8329995B2 (en) 2007-07-06 2012-12-11 Arcadia Biosciences, Inc. Soybeans with reduced isoflavones
AU2011268698B2 (en) 2010-06-22 2015-03-05 Sun Pharmaceutical Industries (Australia) Pty Ltd Methyltransferase nucleic acids and polypeptides
ES2905123T3 (es) 2010-07-22 2022-04-07 Sun Pharmaceutical Industries Australia Pty Ltd Citocromo P450 de plantas
GB201204407D0 (en) * 2012-03-13 2012-04-25 Glaxosmithkline Australia Pty Ltd Nucleic acid molecule
CN114409752B (zh) * 2022-01-27 2023-11-14 福建农林大学 GmUVR8基因家族在提高植物异黄酮含量中的应用
CN116926051B (zh) * 2023-09-19 2023-11-24 佛山市汇腾生物技术有限公司 一种查耳酮异构酶突变体及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
ES2018274T5 (es) 1986-03-11 1996-12-16 Plant Genetic Systems Nv Celulas vegetales resistentes a los inhibidores de glutamina sintetasa, preparadas por ingenieria genetica.
US5107065A (en) 1986-03-28 1992-04-21 Calgene, Inc. Anti-sense regulation of gene expression in plant cells
US5231020A (en) 1989-03-30 1993-07-27 Dna Plant Technology Corporation Genetic engineering of novel plant phenotypes
US5750399A (en) * 1994-11-14 1998-05-12 The Samuel Roberts Noble Foundation, Inc. Isoflavone reductase promoter

Also Published As

Publication number Publication date
EP1015614A1 (en) 2000-07-05
US6617493B1 (en) 2003-09-09
WO1999014351A1 (en) 1999-03-25
US6054636A (en) 2000-04-25
US6521433B1 (en) 2003-02-18
AU9493498A (en) 1999-04-05

Similar Documents

Publication Publication Date Title
BR9815632A (pt) Fragmento de ácido nucléico isolado e método de obtenção do mesmo, gene quimérico, célula hospedeira transformada, método de alteração do nìvel de expressão de uma enzima e produto
WO2000032757A3 (en) Plant vitamin e biosynthetic enzymes
WO1999055888A3 (en) Carotenoid biosynthesis enzymes
BR9908858A (pt) Fragmento de ácido nucléico isolado, gene quimérico, célula hospedeira transformada, polipeptìdio, método de alteração do nìvel de expressão de uma proteìna, método de obtenção de um fragmento de ácido nucléico e produto.
BR9809967A (pt) Fragmento de ácido nucleico isolado, gene quimérico, célula hospedeira transformada, polipeptìdeo, método de alteração do nìvel de expressão de uma enzima, método de obtenção de um fragmento de ácido nucleico, produto e método para avaliação da capacidade de pelo menos um composto em inibir a atividade de uma enzima
BR9815537A (pt) Fragmento de ácido nucleico isolado, gene quimérico, célula hospedeira, planta, semente da planta e de soja, método de alteração do nìvel de expressão de uma enzima, método para a produção de ácidos graxos epoxidados e para a produção de uma enzima, método de obtenção de um fragmento de ácido nucleico e produto
BR9908381A (pt) Fragmento de ácido nucléico isolado, gene quimérico, célula hospedeira transformada, polipetìdio, processo de alteração do nìvel de expressão de uma enzima, método de produção de um ácido graxo dessaturado, semente, óleo, método de produção de óleo de semente, método de obtenção de um fragmento de ácido nucléico e produto
NO20030229D0 (no) Et cytokrom P450 enzym assosiert med syntesen av &lt;delta&gt;12- epoksygrupper i fettsyrene til plantene
Ying et al. Rubisco small and large subunitN-methyltransferases: Bi-and mono-functional methyltransferases that methylate the small and large subunits of rubisco
ID27760A (id) Poliketida-poliketida, pembuatannya, dan bahan-bahan untuk penggunaannya
AU9123598A (en) High fidelity polymerases and uses thereof
WO1999049058A3 (en) Tryptophan biosynthetic enzymes
HUP0200286A2 (hu) Izoflavon-szintetázt kódoló nukleinsav-szekvenciák
AU8762701A (en) Method for influencing the content of sinapine in transgenic plant cells and plants
BR9815487A (pt) Fragmento de ácido nucleico isolado gene quimérico, célula hospedeira transformada, polipeptìdeo de 4-alfa-glucanotransferase de trigo, método de alteração do nìvel de expressão de uma 4-alfa-glucanotransferase, método de obtenção de um fragmento de ácido mucleico e produto
WO2000032792A3 (en) Plant 1-deoxy-d-xylulose 5-phosphate synthase
WO2000037652A3 (en) Flavonoid biosynthetic enzymes
BR9815519A (pt) Fragmento de ácido nucleico isolado, gene quimérico, célula hospedeira transformada, método de alteração do nìvel de expressão de uma glicogenina vegetal, método de obtenção de um fragmento de ácido nucleico isolado e produto
BR9813919A (pt) Fragmento de ácido nucléico isolado, gene quimérico, célula hospedeira transformada, polipeptìdeo sclb^ r^, método de alteração do nìvel de expressão de uma proteìna sclb^ r^, método para obtenção de um fragmento de ácido nucléico e produto
WO2000060087A3 (en) Cyclin dependent kinase inhibitor genes from plants
BR9809736A (pt) Fragmento de ácido nucleico, gene quimérico, célula hospedeira, método de alteração do nìvel de expressão de uma proteìna, método de obtenção de um fragmento de ácido nucleico e produto
Kohlstock et al. Cys359 of GrdD is the active‐site thiol that catalyses the final step of acetyl phosphate formation by glycine reductase from Eubacterium acidaminophilum
WO2002016565A3 (en) Nucleotide sequences of a new class of diverged delta-9 stearoyl-acp desaturase genes
BR9907965A (pt) Fragmento de ácido nucléico isolado, gene quimérico, célula hospedeira transformada, polipetìdios, processo de alteração do nìvel de expressão de uma proteìna ciclina em uma célula hospedeira, método de obtenção de um fragmento de ácido nucleìco, produto e método de avaliação de pelo menos um composto quanto à sua capacidade de inibir a atividade de uma proteìna ciclina
BR9908100A (pt) Fragmento de ácido nucléico isolado, gene quimérico, célula hospedeira transformada, polipeptìdeo, método de alteração do nìvel de expressão de uma enzima biossintética de carboidrato em uma célula hospedeira, método de obtenção de um fragmento de ácido nucléico e produto

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired